Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Dec;26(6):930–932. doi: 10.1128/aac.26.6.930

In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease.

R J Chiodini, H J Van Kruiningen, W R Thayer, J A Coutu, R S Merkal
PMCID: PMC180053  PMID: 6524906

Abstract

The in vitro susceptibility of three strains of an unclassified Mycobacterium sp., isolated from three patients with Crohn's disease, to 23 antimicrobial agents was determined by a modified broth dilution method with 7H9 broth containing oleic acid-albumin-dextrose-catalase, Tween 80, and mycobactin J. All three strains were susceptible to streptomycin, viomycin, rifampin, clofazimine, cefazolin, amikacin, and kanamycin and resistant to p-aminosalicylic acid, cycloserine, 2-thiophenecarboxylic acid hydrazide, trimethoprim, diaminodiphenylsulfone, sulfamethoxazole, sulfadimethoxine, polymyxin B, metronidazole, neomycin, and carbenicillin. Variable results between strains were encountered with ethambutol, ethionamide, capreomycin, amoxicillin, and cephalothin.

Full text

PDF
930

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azadkhan A. K., Truelove S. C., Aronson J. K. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol. 1982 Apr;13(4):523–528. doi: 10.1111/j.1365-2125.1982.tb01415.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chiodini R. J., Van Kruiningen H. J., Merkal R. S., Thayer W. R., Jr, Coutu J. A. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J Clin Microbiol. 1984 Nov;20(5):966–971. doi: 10.1128/jcm.20.5.966-971.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiodini R. J., Van Kruiningen H. J., Thayer W. R., Merkal R. S., Coutu J. A. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease. Dig Dis Sci. 1984 Dec;29(12):1073–1079. doi: 10.1007/BF01317078. [DOI] [PubMed] [Google Scholar]
  4. Cynamon M. H., Palmer G. S. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1983 Sep;24(3):429–431. doi: 10.1128/aac.24.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cynamon M. H., Patapow A. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin. Antimicrob Agents Chemother. 1981 Jan;19(1):205–207. doi: 10.1128/aac.19.1.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krook A., Järnerot G., Danielsson D. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. Scand J Gastroenterol. 1981;16(4):569–575. doi: 10.3109/00365528109182013. [DOI] [PubMed] [Google Scholar]
  7. Mizuguchi Y., Udou T., Yamada T. Mechanism of antibiotic resistance in Mycobacterium intracellulare. Microbiol Immunol. 1983;27(5):425–431. doi: 10.1111/j.1348-0421.1983.tb00601.x. [DOI] [PubMed] [Google Scholar]
  8. Rasmussen S. N., Binder V., Maier K., Bondesen S., Fischer C., Klotz U., Hansen S. H., Hvidberg E. F. Treatment of Crohn's disease with peroral 5-aminosalicylic acid. Gastroenterology. 1983 Dec;85(6):1350–1353. [PubMed] [Google Scholar]
  9. Rastogi N., Frehel C., Ryter A., Ohayon H., Lesourd M., David H. L. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrob Agents Chemother. 1981 Nov;20(5):666–677. doi: 10.1128/aac.20.5.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Thayer W. R., Jr, Coutu J. A., Chiodini R. J., Van Kruiningen H. J., Merkal R. S. Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease. Dig Dis Sci. 1984 Dec;29(12):1080–1085. doi: 10.1007/BF01317079. [DOI] [PubMed] [Google Scholar]
  11. Van Hees P. A., Van Lier H. J., Van Elteren P. H., Driessen M., Van Hogezand R. A., Ten Velde G. P., Bakker J. H., Van Tongeren J. H. Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. Gut. 1981 May;22(5):404–409. doi: 10.1136/gut.22.5.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wallace R. J., Jr, Swenson J. M., Silcox V. A., Good R. C. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol. 1982 Dec;16(6):1003–1006. doi: 10.1128/jcm.16.6.1003-1006.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES